Tmunity UC San Francisco collaborate to advance TCR T cell therapies for pediatric cancers

Tmunity, UC San Francisco collaborate to advance TCR T cell therapies for pediatric cancers

03:56 EDT 2 May 2019 | Pharmaceutical Business Review

Initially, research will focus on Diffuse Intrinsic Pontine Glioma (DIPG), a rare and highly aggressive brain stem tumor. As part of the research collaboration, Tmunity will work with

More From BioPortfolio on "Tmunity, UC San Francisco collaborate to advance TCR T cell therapies for pediatric cancers"